Patents by Inventor Annemarie Elizabeth Silver
Annemarie Elizabeth Silver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11813084Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).Type: GrantFiled: June 17, 2021Date of Patent: November 14, 2023Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Ulrich Herken, Christopher Kaufman, Annemarie Elizabeth Silver
-
Patent number: 11816322Abstract: A system for medical data review and playback includes a medical device including sensors configured to collect patient data during a medical event, a display screen, and a communication port configured to access a WAN, a processor configured to receive the patient data, control the display screen to display the patient data during the medical event, communicably couple to a database, and provide the patient data to the database, and a playback interface display configured to access the database, and provide the playback interface configured to permit sequential playback of the patient data and including visual representations of the patient data displayed at the medical device display screen, and a visual timeline representing times during the medical event and including a timeline indicator configured to move the sequential playback of the patient data to a user-selected time during the medical event in response to user input.Type: GrantFiled: March 10, 2021Date of Patent: November 14, 2023Assignee: ZOLL Medical CorporationInventors: Gary A Freeman, Annemarie Elizabeth Silver
-
Publication number: 20230277138Abstract: Embodiments of the present invention include a system having at least one sensor configured to monitor a muscle oxygen saturation (SmO2) level of a patient who is undergoing cardiac arrest and to generate a signal representing SmO2 level; a user interface device; a processor communicably coupled to the user interface device, the processor configured to cause the user interface device to present an array of two or more possible nodes of a clinical decision support tree, wherein at least one of the nodes indicates cardiopulmonary resuscitation (CPR) treatment of the patient with no ventilation, and wherein at least another of the nodes indicates CPR treatment of the patient with active ventilation; determine which of the two or more possible nodes should be emphasized based on the SmO2 level; and update the array of the two or more possible nodes based on the determination.Type: ApplicationFiled: March 8, 2023Publication date: September 7, 2023Inventors: Gary A. Freeman, Annemarie Elizabeth Silver
-
Patent number: 11622726Abstract: Embodiments of the present invention include a system having at least one sensor configured to monitor a muscle oxygen saturation (SmO2) level of a patient who is undergoing cardiac arrest and to generate a signal representing SmO2 level; a user interface device; a processor communicably coupled to the user interface device, the processor configured to cause the user interface device to present an array of two or more possible nodes of a clinical decision support tree, wherein at least one of the nodes indicates cardiopulmonary resuscitation (CPR) treatment of the patient with no ventilation, and wherein at least another of the nodes indicates CPR treatment of the patient with active ventilation; determine which of the two or more possible nodes should be emphasized based on the SmO2 level; and update the array of the two or more possible nodes based on the determination.Type: GrantFiled: March 27, 2014Date of Patent: April 11, 2023Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Annemarie Elizabeth Silver
-
Publication number: 20220039746Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).Type: ApplicationFiled: June 17, 2021Publication date: February 10, 2022Inventors: Gary A. FREEMAN, Ulrich HERKEN, Christopher KAUFMAN, Annemarie Elizabeth SILVER
-
Publication number: 20210303143Abstract: A system for medical data review and playback includes a medical device including sensors configured to collect patient data during a medical event, a display screen, and a communication port configured to access a WAN, a processor configured to receive the patient data, control the display screen to display the patient data during the medical event, communicably couple to a database, and provide the patient data to the database, and a playback interface display configured to access the database, and provide the playback interface configured to permit sequential playback of the patient data and including visual representations of the patient data displayed at the medical device display screen, and a visual timeline representing times during the medical event and including a timeline indicator configured to move the sequential playback of the patient data to a user-selected time during the medical event in response to user input.Type: ApplicationFiled: March 10, 2021Publication date: September 30, 2021Inventors: Gary A Freeman, Annemarie Elizabeth Silver
-
Patent number: 11058356Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).Type: GrantFiled: March 29, 2019Date of Patent: July 13, 2021Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Ulrich Herken, Christopher Kaufman, Annemarie Elizabeth Silver
-
Patent number: 10976908Abstract: Embodiments of the present invention include systems and methods for display and navigation of a clinical decision support process with portions thereof on separate display screens, as well as systems and methods for dynamically changing visual characteristics of softkeys on a patient monitor/defibrillator user interface screen based on clinical decision support or differential diagnosis processes, as well as a code review interface configured to permit a user to see what was displayed on a patient monitor/defibrillator user interface screen at any time during a medical event, as well as to see snapshots of other recorded parameters over the course of the medical event for purposes of code review, patient transfer, and improved patient care.Type: GrantFiled: April 26, 2017Date of Patent: April 13, 2021Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Annemarie Elizabeth Silver
-
Patent number: 10799177Abstract: A system for non-invasively measuring a physiologic status patient tissue according to an embodiment includes a housing; an optical spectroscope with a wavelength-sensitive sensor capable of detecting light intensity, at two or more distinct wavelengths, of light scattered and/or reflected by muscle tissue of the patient in order to measure a physiologic status of the muscle tissue, a bioimpedance sensor at least partially disposed within the housing, the bioimpedance sensor configured to generate a signal corresponding to an estimation of a thickness of an adipose tissue layer between the optical spectroscope and the muscle tissue, and a processor configured to (1) receive the estimations of the thickness, (2) compare the estimations of the thickness, and (3) based on the comparison, generate a visual indication configured to assist in placement of the housing toward or at a location corresponding to the smaller or smallest thickness of the adipose tissue layer.Type: GrantFiled: March 22, 2016Date of Patent: October 13, 2020Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Ulrich Herken, Christopher L. Kaufman, Annemarie Elizabeth Silver
-
Publication number: 20200305722Abstract: Embodiments of the present disclosure relate generally to the use of spectral sensors during a cardiac arrest event. More specifically, the present disclosure relates to the use of spectral sensors for measuring changes in pH and muscle oxygen saturation to estimate subject down time and evaluating the effectiveness of the clinical treatment administered during a cardiac arrest event. Given the narrow window of time in which emergency treatment must be administered, as well as the lack of information concerning the subject's condition, there is a need for a fast and accurate method of estimating the onset of the cardiac arrest emergency and evaluating the effectiveness of the emergency treatment being administered.Type: ApplicationFiled: March 5, 2020Publication date: October 1, 2020Inventors: Gary A. Freeman, Ulrich Herken, Christopher L. Kaufman, Annemarie Elizabeth Silver
-
Patent number: 10617347Abstract: Embodiments of the present disclosure relate generally to the use of spectral sensors during a cardiac arrest event. More specifically, the present disclosure relates to the use of spectral sensors for measuring changes in pH and muscle oxygen saturation to estimate subject down time and evaluating the effectiveness of the clinical treatment administered during a cardiac arrest event. Given the narrow window of time in which emergency treatment must be administered, as well as the lack of information concerning the subject's condition, there is a need for a fast and accurate method of estimating the onset of the cardiac arrest emergency and evaluating the effectiveness of the emergency treatment being administered.Type: GrantFiled: March 21, 2016Date of Patent: April 14, 2020Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Ulrich Herken, Christopher L. Kaufman, Annemarie Elizabeth Silver
-
Patent number: 10378972Abstract: Systems and methods for determining validity of physiological data according to an embodiment of the present invention include a patient sensor configured to acquire patient data from a patient, wherein the patient data is physiological; and an environmental sensor configured to acquire environmental data related to validity of the patient data, wherein a value of the environmental data has a clinical effect on the validity of the patient data but not on performance of the environmental sensor; a control/monitoring system, wherein the control/monitoring system is configured to determine whether the environmental data satisfies one or more conditions indicative of the validity of the patient data and to flag the patient data that is invalid based on the determination.Type: GrantFiled: November 11, 2014Date of Patent: August 13, 2019Assignee: ZOLL MEDICAL CORPORATIONInventors: Annemarie Elizabeth Silver, Gary A. Freeman
-
Publication number: 20190223794Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).Type: ApplicationFiled: March 29, 2019Publication date: July 25, 2019Inventors: Gary A. FREEMAN, Ulrich HERKEN, Christopher KAUFMAN, Annemarie Elizabeth SILVER
-
Patent number: 10349875Abstract: Near-infrared spectroscopy (NIRS) is used to measure parameters such as pH of muscle tissue of a patient that is affected by a cardiac arrest. Analysis of the pH and other parameters such as SmO2 facilitates distinguishing between an arrhythmia arrest and an asphyxia arrest.Type: GrantFiled: September 30, 2016Date of Patent: July 16, 2019Assignee: ZOLL MEDICAL CORPORATIONInventors: Gary A. Freeman, Ulrich Herken, Christopher L. Kaufman, Annemarie Elizabeth Silver
-
Patent number: 10278646Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).Type: GrantFiled: October 29, 2015Date of Patent: May 7, 2019Assignee: ZOLL MEDICAL CORPORATIONInventors: Gary A. Freeman, Ulrich Herken, Christopher Kaufman, Annemarie Elizabeth Silver
-
Patent number: 10258281Abstract: A disposable patient interface includes a reusable sensor that removably mounts within a shoe of the disposable patient interface when at least one protrusion on opposite ends of the sensor removably lock with corresponding at least one aperture on opposite portions of the shoe. The patient interface includes a compliant structure which conforms to a patient's body upon placement thereon without causing wrinkles in the compliant structure so as to maximize adhesion of the compliant structure against skin on the patient's body when the compliant structure is conformed to muscle underlying skin on the patient's body.Type: GrantFiled: November 29, 2017Date of Patent: April 16, 2019Assignee: ZOLL MEDICAL CORPORATIONInventors: Steven J. Weisner, Peter J. Scott, Gwenn Ellerby, John Cain, Sean M. Frick, Babs R. Soller, Ulrich R. Herken, Annemarie Elizabeth Silver, Gary A. Freeman
-
Publication number: 20180146924Abstract: A disposable patient interface includes a reusable sensor that removably mounts within a shoe of the disposable patient interface when at least one protrusion on opposite ends of the sensor removably lock with corresponding at least one aperture on opposite portions of the shoe. The patient interface includes a compliant structure which conforms to a patient's body upon placement thereon without causing wrinkles in the compliant structure so as to maximize adhesion of the compliant structure against skin on the patient's body when the compliant structure is conformed to muscle underlying skin on the patient's body.Type: ApplicationFiled: November 29, 2017Publication date: May 31, 2018Inventors: Steven J. WEISNER, Peter J. SCOTT, Gwenn ELLERBY, John CAIN, Sean M. FRICK, Babs R. SOLLER, Ulrich R. HERKEN, Annemarie Elizabeth SILVER, Gary A. FREEMAN
-
Publication number: 20170293726Abstract: Embodiments of the present invention include systems and methods for display and navigation of a clinical decision support process with portions thereof on separate display screens, as well as systems and methods for dynamically changing visual characteristics of softkeys on a patient monitor/defibrillator user interface screen based on clinical decision support or differential diagnosis processes, as well as a code review interface configured to permit a user to see what was displayed on a patient monitor/defibrillator user interface screen at any time during a medical event, as well as to see snapshots of other recorded parameters over the course of the medical event for purposes of code review, patient transfer, and improved patient care.Type: ApplicationFiled: April 26, 2017Publication date: October 12, 2017Inventors: Gary A. FREEMAN, Annemarie Elizabeth SILVER
-
Patent number: 9658756Abstract: Embodiments of the present invention include systems and methods for display and navigation of a clinical decision support process with portions thereof on separate display screens, as well as systems and methods for dynamically changing visual characteristics of softkeys on a patient monitor/defibrillator user interface screen based on clinical decision support or differential diagnosis processes, as well as a code review interface configured to permit a user to see what was displayed on a patient monitor/defibrillator user interface screen at any time during a medical event, as well as to see snapshots of other recorded parameters over the course of the medical event for purposes of code review, patient transfer, and improved patient care.Type: GrantFiled: January 9, 2014Date of Patent: May 23, 2017Assignee: ZOLL Medical CorporationInventors: Gary A. Freeman, Annemarie Elizabeth Silver
-
Publication number: 20170086719Abstract: Near-infrared spectroscopy (NIRS) is used to measure parameters such as pH of muscle tissue of a patient that is affected by a cardiac arrest. Analysis of the pH and other parameters such as SmO2 facilitates distinguishing between an arrhythmia arrest and an asphyxia arrest.Type: ApplicationFiled: September 30, 2016Publication date: March 30, 2017Inventors: Gary A. FREEMAN, Ulrich HERKEN, Christopher L. KAUFMAN, Annemarie Elizabeth SILVER